Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00246_DB01200_nanopub.RAYWA5yoND2ujWbEg2gEUjMCC1-SJt2I5HgihLDjbtiXk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00246_DB01200 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00246_DB01200 label "DDI between Ziprasidone and Bromocriptine - The atypical antipsychotic, ziprasidone, may antagonize the effect of the dopamine agonist, bromocriptine. Consider alternate therapy or monitor for worsening of movement disorder. [drugbank_resource:DB00246_DB01200]" assertion.
- drugbank_resource:DB00246_DB01200 identifier "drugbank_resource:DB00246_DB01200" assertion.
- drugbank_resource:DB00246_DB01200 title "DDI between Ziprasidone and Bromocriptine - The atypical antipsychotic, ziprasidone, may antagonize the effect of the dopamine agonist, bromocriptine. Consider alternate therapy or monitor for worsening of movement disorder." assertion.
- drugbank:DB00246 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01200 assertion.
- drugbank:DB01200 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00246_DB01200 assertion.